← Back to Patent Explorer
US4703011A Expired / Lapsed US ⏱️ 0.0 years remaining

Thymidine kinase deletion mutants of bovine herpesvirus-1

Assignee: Baylor College of Medicine
•
Filing: 1985-11-12
•
Granted: 1987-10-27
•
Expires: 2005-11-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Bovine herpesvirus type 1 (infectious bovine rhinotracheitis virus) mutants which fail to produce any functional thymidine kinase as a result of a deletion in the thymidine kinase gene. The deletion in the thymidine kinase gene attenuates the viruses so that they can be used as an active agent in a modified live-virus vaccine against infectious bovine rhinotracheitis. This invention also relates to methods for the production and use of the same.

Inventors

  • 👤 Malon Kit
  • 👤 Saul Kit

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 19:48
CPC Classifications
C; C12; C12N; C12N15/00; A; A61; A61K; A61K39/00; A61K39/12; A61K39/245; C12N2710/00; C12N2710/00011; C12N2710/16011; C12N2710/16711; C12N2710/16734; Y; Y10; Y10S; Y10S424/00; Y10S424/813; Y10S424/822; Y10S930/00; Y10S930/01; Y10S930/22; Y10S930/224

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 22 words
An infectious bovine rhinotracheitis virus which fails to produce any functional TK as a result of a deletion in the tk gene.
Claim 2
Dependent Claim 22 words
An infectious bovine rhinotracheitis virus which fails to produce any functional TK as a result of a deletion in the tk gene.
Claim 3
Dependent Claim 21 words
The infectious bovine rhinotracheitis virus as claimed in claim 1, wherein said deletion is about 10 to 1500 bp in size.
Claim 4
Dependent Claim 21 words
The infectious bovine rhinotracheitis virus as claimed in claim 2, wherein said deletion is about 75 to 750 bp in size.
Claim 5
Dependent Claim 16 words
The infectious bovine rhinotracheitis virus as claimed in claim 1, wherein said virus is temperature resistant.
Claim 6
Dependent Claim 24 words
The infectious bovine rhinotracheitis virus as claimed in claim 1, wherein an oligonucleotide linker is present in the deletion site of the tk gene.
Claim 7
Dependent Claim 21 words
The infectious bovine rhinotracheitis virus as claimed in claim 5, wherein said linker is about 7 to 50 nucleotides in length.
Claim 8
Dependent Claim 26 words
The infectious bovine rhinotracheitis virus as claimed in claim 1, wherein said virus has the identifying characteristics of IBRV(NG) dl TK clone 1 (ATCC No. VR-2112).
Claim 9
Dependent Claim 15 words
The infectious bovine rhinotracheitis virus as claimed in claim 1, wherein said virus is lyophilized.
Claim 10
Dependent Claim 190 words
An infectious bovine rhinotracheitis virus which fails to produce any functional TK as a result of a deletion in the tk gene produced by the process comprising: (1) constructing a hybrid plasmid comprising a cloning vector and a DNA fragment of IBRV containing substantially all of the IBRV tk gene; (2) co-transfecting, in tk + host cells, the hybrid plasmid of step (1) with infectious DNA from a tk - IBRV mutagen-induced mutant; (3) selecting, in tk - host cells, for tk + IBRB from the virus produced in step (2); (4) deleting DNA sequences from the hybrid plasmid of step (1) such that less than substantially all of the IBRV tk gene is present; (5) co-transfecting, in tk + host cells, IBRV tk + DNA derived from the tk + IBRV obtained in step (3) with the resulting tk - hybrid plasmid of step (4); and (6) selecting, in tk - host cells, for tk - IBRV from the virus produced in step (5) so as to produce tk - IBRV mutants which fail to produce any functional TK as a result of a deletion in the tk gene.
Claim 11
Dependent Claim 190 words
An infectious bovine rhinotracheitis virus which fails to produce any functional TK as a result of a deletion in the tk gene produced by the process comprising: (1) constructing a hybrid plasmid comprising a cloning vector and a DNA fragment of IBRV containing substantially all of the IBRV tk gene; (2) co-transfecting, in tk + host cells, the hybrid plasmid of step (1) with infectious DNA from a tk - IBRV mutagen-induced mutant; (3) selecting, in tk - host cells, for tk + IBRB from the virus produced in step (2); (4) deleting DNA sequences from the hybrid plasmid of step (1) such that less than substantially all of the IBRV tk gene is present; (5) co-transfecting, in tk + host cells, IBRV tk + DNA derived from the tk + IBRV obtained in step (3) with the resulting tk - hybrid plasmid of step (4); and (6) selecting, in tk - host cells, for tk - IBRV from the virus produced in step (5) so as to produce tk - IBRV mutants which fail to produce any functional TK as a result of a deletion in the tk gene.
Claim 12
Dependent Claim 21 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein said deletion is about 10 to 1500 bp in size.
Claim 13
Dependent Claim 21 words
The infectious bovine rhinotracheitis virus as claimed in claim 10, wherein said deletion is about 75 to 750 bp in size.
Claim 14
Dependent Claim 42 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein the tk - IBRV mutagen-induced mutant in step (2) is a temperature-resistant mutant such that the resulting mutant in step (6) is both temperature resistant and a tk - deletion mutant.
Claim 15
Dependent Claim 74 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, additionally comprising step (7): (7) propagating the resulting IBRV which fails to produce any functional TK as a result of a deletion in the tk gene of step (6) at a non-permissive temperature for a temperature-sensitive virus so as to select for and produce a temperature-resistant IBRV which fails to produce any functional TK as a result of a deletion in the tk gene.
Claim 16
Dependent Claim 40 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein an oligonucleotide linker is present in the deletion site of the IBRV DNA of step (4) while retaining IBRV DNA sequences adjacent to each side of the deletion site.
Claim 17
Dependent Claim 21 words
The infectious bovine rhinotracheitis virus as claimed in claim 14, wherein said linker is about 7 to 50 nucleotides in length.
Claim 18
Dependent Claim 15 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein said virus is lyophilized.
Claim 19
Dependent Claim 37 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein said cloning vector is selected from the group consisting of pBR322, pMB9, pBR325, pKH47, pBR328, pHC79, phage Charon 28, pKB11, pKSV-10, pMAR420 and oligo (dG)-tailed pBR322.
Claim 20
Dependent Claim 16 words
The infectious bovine rhinotracheitis virus as claimed in claim 17, wherein said cloning vector is pBR322.
Claim 21
Dependent Claim 21 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein said hybrid plasmid of step (1) is pLATK dl NdeI.
Claim 22
Dependent Claim 32 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein in step (4) the IBRV DNA sequences adjacent to each side of the deletion are at least 400 bp in size.
Claim 23
Dependent Claim 24 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein the resulting hybrid plasmid of step (4) is pLATK dl NdeI dl BgII/NG/SstI.
Claim 24
Dependent Claim 72 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein said tk + host cells are selected from the group consisting of RAB-9 (ATCC No. CRL-1414); primary rabbit kidney cells, secondary rabbit kidney cells; rabbit cornea (SIRC) cells (ATCC No. CCL-60), rabbit kidney (LLC-RK1) cells (ATCC No. CCL-106), embryo bovine trachea (EBTR) cells (ATCC No. CCL-44), bovine turbinate (BT) cells (ATCC No. CRL-1390), and bovine kidney (MDBK) cells (ATCC No. CCL-22).
Claim 25
Dependent Claim 18 words
The infectious bovine rhinotracheitis virus as claimed in claim 22, wherein said tk + host cells are RAB-9.
Claim 26
Dependent Claim 38 words
The infectious bovine rhinotracheitis virus as claimed in claim 9, wherein the tk - IBRV mutagen-induced mutant is selected from the group consisting of the non-temperature-resistant bromovinyldeoxyuridine-resistant IBRV mutant of IBRV(P8-2) and the temperature-resistant IBRV(B8-D53) (ATCC No. VR-2066).
Claim 27
Dependent Claim 24 words
The infectious bovine rhinotracheitis virus as claimed in claim 24, wherein the tk - IBRV mutagen-induced mutant is the temperature-resistant IBRV(B8-D53) (ATCC No. VR-2066).

References Cited (Backward Citations)

US3634587A Cited
US3925544A Cited
US4291019A Cited
US4569840A Cited
EP0141458A1 Cited
US4514497A Cited
US4514497B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-10-26 1991-04-27 1991-10-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-10-26 1995-04-27 1995-10-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-10-26 1999-04-27 1999-10-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag